49571-31-5

Upstream product

• 444-29-1 2-iodo(trifluoromethyl)benzene 
• 31600-86-9 2-methoxyphenyllithium 
• 2786-01-8 (4-trifluoromethylphenyl)lithium 
• 5792-36-9 2',4'-dihydroxypropiophenone 
• 392-83-6 o-trifluoromethylphenyl bromide 

Downstream Products

• 156814-15-2 C₉H₁₀ClF₃NP 
• 348-53-8 2-fluorophenyl lithium 
• 334778-34-6 2-(trifluoromethoxy)phenyllithium 
• 25688-44-2 [2-(trifluoromethyl)phenyl]diphenylphosphine 
• 384-18-9 me2(ph-2-CF₃)SiCl 
• 871112-34-4 tert-butyl 4-hydroxy-4-(2-(trifluoromethyl)phenyl)piperidine-1-carboxylate 
• 40503-38-6 Methanesulfonic acid 4-(2-trifluoromethyl-phenyl)-cyclohex-3-enyl ester 
• 40503-19-3 4-hydroxy-4-(2-(trifluoromethyl)phenyl)cyclohexan-1-one 
• 156814-12-9 C₁₁H₁₆F₃N₂P 
• 1455270-79-7 C₁₄H₁₃F₃O 
• 1274800-70-2 C₁₄H₁₅F₃O 

Relevant academic research and scientific papers

Relative basicities of ortho-, meta-, and para-substituted aryllithiums

(Chemical Equation Presented) The relative basicities of aryllithiums bearing methoxy, chlorine, fluorine, trifluoromethyl and trifluoromethoxy substituents at the ortho, meta, and para positions have been assessed. To this end, two aryllithiums of compar

Hydroxamic acid derivatives as metalloprotease inhibitors

The present invention provides compounds of Formula I or II: salt form or prodrug thereof, wherein variables are defined herein, that are modulators of metalloproteases such as matrix metalloproteases (MMPs) and ADAMs. The compounds or compositions descri

Resorcin derivatives, process for their preparation and pharmaceutical compositions containing them

The invention relates to new resorcin derivatives of the formula (I) STR1 wherein R1 and R2 independently represent hydrogen, halogen, trihalomethyl, alkyl having from one to 3 carbon atoms or alkoxy having from one to 3 carbon atoms